ArticleBreast cancer research and treatment2013

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.

Cynthia X Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.